HNB
TRAW icon

Huntington National Bank’s Traws Pharma TRAW Stock Holding History

Huntington National Bank’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.94K Buy
+4,676
New +$6.44K ﹤0.01% 2303

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Huntington National Bank's TRAW Position: Q2 2026 in Review

Huntington National Bank opened a new position in Traws Pharma (TRAW) in Q2 2026: 4,676 shares worth $3.94K. The stake represents ﹤0.01% of the portfolio and ranks #2303 among its holdings.

35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Huntington National Bank held 4,676 shares of Traws Pharma worth $3.94K as of Q2 2026.
  • Traws Pharma was a new Huntington National Bank position in Q2 2026.
  • Traws Pharma made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2303 holding.
  • 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.